News

Ferronomics – some of the financial considerations of IDA

Monday, 21 March 2016

The NHS classifies IDA as a condition that commissioners should be prioritising when trying to reduce non-elective hospital admissions (emergency admissions). Non-elective IDA admissions have been identified amongst a group of other conditions as being preventable through appropriate interventions in preventative and primary care.1 Despite this, the management of IDA is often suboptimal, with many patients being incompletely investigated, if not at all.2

References:
1 King’s Fund (2012) ‘Emergency hospital admissions for ambulatory care-sensitive conditions: identifying the potential for reductions’, http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/data-briefing-emergency-hospital-admissions-for-ambulatory-care-sensitive-conditions-apr-2012.pdf (accessed Feb 2016)
2 Goddard A, James M, McIntyre A and Scott B (2011) ‘Guidelines for the management of iron deficiency anaemia’, Gut 60, 1309-1316

  • 1-cost-ida.png
    1-cost-ida.png
  • 2-facts-ida.png
    2-facts-ida.png
  • 3-what-is-IDA.JPG
    3-what-is-IDA.JPG
  • 4-symptoms-ida.JPG
    4-symptoms-ida.JPG
  • 5-ida-in-the-nhs.JPG
    5-ida-in-the-nhs.JPG

Contact

Vifor Pharma UK Limited

The Old Stables, Bagshot Park, Bagshot
Surrey-UK GU19 5PJ

Phone:
+44 1276 853 600
Fax:
+44 1276 452 341

Send link

Send as link



Links